These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 19596957)

  • 1. Efficacy of a lumbo-peritoneal shunt for meningeal carcinomatosis refractory to gefitinib treatment.
    Kubo T; Takigawa N; Kiura K; Nishida A; Ochi N; Kashihara H; Umemura S; Hisamoto A; Tanimoto M
    Anticancer Res; 2009 Jul; 29(7):2759-60. PubMed ID: 19596957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of meningeal carcinomatosis of lung adenocarcinoma well controlled by re-treatment with gefitinib].
    Kumamoto T; Suetsugu T; Iwakawa J; Tanoue A; Kawamata Y
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2615-7. PubMed ID: 20009465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR mutation status in pleural fluid predicts tumor responsiveness and resistance to gefitinib.
    Soh J; Toyooka S; Ichihara S; Suehisa H; Kobayashi N; Ito S; Yamane M; Aoe M; Sano Y; Kiura K; Date H
    Lung Cancer; 2007 Jun; 56(3):445-8. PubMed ID: 17335935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy.
    Masuda T; Hattori N; Hamada A; Iwamoto H; Ohshimo S; Kanehara M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Kohno N
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1465-9. PubMed ID: 21274533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful EGFR-TKI rechallenge of leptomeningeal carcinomatosis after gefitinib-induced interstitial lung disease.
    Nakamichi S; Kubota K; Horinouchi H; Kanda S; Fujiwara Y; Nokihara H; Yamamoto N; Tamura T
    Jpn J Clin Oncol; 2013 Apr; 43(4):422-5. PubMed ID: 23410901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gefitinib and a ventriculo-peritoneal shunt to manage carcinomatous meningitis from non-small-cell lung cancer: report of two cases.
    So T; Inoue M; Chikaishi Y; Nose N; Sugio K; Yasumoto K
    Surg Today; 2009; 39(7):598-602. PubMed ID: 19562448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Two cases of meningeal carcinomatosis during gefitinib therapy for non-small cell lung cancer].
    Abe T; Hayashi M; Tsutsui N; Ito K; Haraguchi M
    Nihon Kokyuki Gakkai Zasshi; 2006 Feb; 44(2):144-9. PubMed ID: 17228810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired resistance to gefitinib: the contribution of mechanisms other than the T790M, MET, and HGF status.
    Onitsuka T; Uramoto H; Nose N; Takenoyama M; Hanagiri T; Sugio K; Yasumoto K
    Lung Cancer; 2010 May; 68(2):198-203. PubMed ID: 19589612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations.
    Kim DW; Lee SH; Lee JS; Lee MA; Kang JH; Kim SY; Shin SW; Kim HK; Heo DS
    Lung Cancer; 2011 Jan; 71(1):65-9. PubMed ID: 20430469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern.
    Wu SG; Chang YL; Hsu YC; Wu JY; Yang CH; Yu CJ; Tsai MF; Shih JY; Yang PC
    Oncologist; 2008 Dec; 13(12):1276-84. PubMed ID: 19060236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Meningeal carcinomatosis in patients with lung cancer].
    Sudo J; Honmura Y; Kurimoto F; Komagata H; Sakai H; Yoneda S
    Nihon Kokyuki Gakkai Zasshi; 2006 Nov; 44(11):795-9. PubMed ID: 17144575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib.
    Kosaka T; Yatabe Y; Endoh H; Yoshida K; Hida T; Tsuboi M; Tada H; Kuwano H; Mitsudomi T
    Clin Cancer Res; 2006 Oct; 12(19):5764-9. PubMed ID: 17020982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.
    Sequist LV; Martins RG; Spigel D; Grunberg SM; Spira A; Jänne PA; Joshi VA; McCollum D; Evans TL; Muzikansky A; Kuhlmann GL; Han M; Goldberg JS; Settleman J; Iafrate AJ; Engelman JA; Haber DA; Johnson BE; Lynch TJ
    J Clin Oncol; 2008 May; 26(15):2442-9. PubMed ID: 18458038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lumbo-peritoneal shunting improved spinal cord compression due to a large anterior sacral meningocele.
    Rukskul P
    J Med Assoc Thai; 2005 Feb; 88(2):265-8. PubMed ID: 15962681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic heterogeneity of EGFR mutation in pleomorphic carcinoma of the lung: response to gefitinib and clinical outcome.
    Ushiki A; Koizumi T; Kobayashi N; Kanda S; Yasuo M; Yamamoto H; Kubo K; Aoyagi D; Nakayama J
    Jpn J Clin Oncol; 2009 Apr; 39(4):267-70. PubMed ID: 19155283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib.
    Omuro AM; Kris MG; Miller VA; Franceschi E; Shah N; Milton DT; Abrey LE
    Cancer; 2005 Jun; 103(11):2344-8. PubMed ID: 15844174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double mutation and gene copy number of EGFR in gefitinib refractory non-small-cell lung cancer.
    Tokumo M; Toyooka S; Ichihara S; Ohashi K; Tsukuda K; Ichimura K; Tabata M; Kiura K; Aoe M; Sano Y; Date H; Shimizu N
    Lung Cancer; 2006 Jul; 53(1):117-21. PubMed ID: 16730855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gefitinib as first-line treatment in elderly epidermal growth factor receptor-mutated patients with advanced lung adenocarcinoma: results of a Nagano Lung Cancer Research Group study.
    Asami K; Koizumi T; Hirai K; Ameshima S; Tsukadaira A; Morozumi N; Morikawa A; Atagi S; Kawahara M
    Clin Lung Cancer; 2011 Nov; 12(6):387-92. PubMed ID: 21729650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Case of leptomeningeal carcinomatosis effectively treated with intrathecal chemotherapy using ventriculoperitoneal shunt].
    Miura M; Iijima N; Hayashida K; Kitazawa K; Ishii K; Ohara S
    Rinsho Shinkeigaku; 2006 Jun; 46(6):404-9. PubMed ID: 16986702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
    Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
    Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.